Charles Schwab Investment Management Inc. lessened its stake in shares of Eagle Bancorp, Inc. (NASDAQ:EGBN) by 1.3% during the fourth quarter, according to the company in its most recent 13F filing wi
Eagle Bancorp, Inc. (NASDAQ:EGBN) hit a new 52-week low during trading on Friday . The company traded as low as $36.23 and last traded at $36.83, with a volume of 4213 shares. The stock had previously
Eagle Bancorp, Inc. (NASDAQ:EGBN) has earned an average recommendation of “Hold” from the ten ratings firms that are currently covering the company, Marketbeat reports. Two investment analysts hav
Barclays PLC lifted its stake in shares of Eagle Bancorp, Inc. (NASDAQ:EGBN) by 23.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional inv
Ron Paul was president, CEO and chairman of Eagle Bancorp and EagleBank until March 2019 when he suddenly retired, citing health reasons.
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll look at Eagle...
Eagle Bancorp (NASDAQ:EGBN) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued on Tuesday, ValuEngine reports. A number of ot
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which declared increased dividends. Companies with upcoming ex-dividend d
American International Group Inc. lowered its stake in Eagle Bancorp, Inc. (NASDAQ:EGBN) by 5.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commiss
Eagle Bancorp (NASDAQ:EGBN) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a note issued to investors on Tuesday, BidAskClub reports. Seve
Equities research analysts expect Eagle Bancorp, Inc. (NASDAQ:EGBN) to announce sales of $85.13 million for the current quarter, Zacks Investment Research reports. Three analysts have provided estimat
The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics
BidaskClub lowered shares of Eagle Bancorp (NASDAQ:EGBN) from a sell rating to a strong sell rating in a research report released on Friday morning, BidAskClub reports. A number of other equities rese
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE